Grifols` Biotest Projects $1B US Sales Of Yimmugo Over 7 Years
01 Jul 2024 //
GLOBENEWSWIRE
Biotest wins FDA approval for plasma protein therapy
17 Jun 2024 //
PHARMACEUTICAL TECHNOLOGY
Biotest AG: Annual General Meeting approves dividend distribution
07 May 2024 //
PHARMIWEB
Biotest AG: Biotest’s Hyperimmunoglobulin Cytotect® CP
04 May 2023 //
BUSINESSWIRE
Biotest and Grifols further strengthen their cooperation
28 Apr 2023 //
PRESS RELEASE
Biotest AG: Biotest receives approval for Intratect(R) in France
29 Nov 2021 //
PHARMIWEB
Grifols drops $1B on German holding company in continued plasma push
18 Sep 2021 //
ENDPTS